Dechra Pharmaceuticals PLC
LSE:DPH
Income Statement
Earnings Waterfall
Dechra Pharmaceuticals PLC
Revenue
|
761.5m
GBP
|
Cost of Revenue
|
-331.9m
GBP
|
Gross Profit
|
429.6m
GBP
|
Operating Expenses
|
-404.7m
GBP
|
Operating Income
|
24.9m
GBP
|
Other Expenses
|
-52.8m
GBP
|
Net Income
|
-27.9m
GBP
|
Income Statement
Dechra Pharmaceuticals PLC
Jun-2003 | Dec-2003 | Jun-2004 | Dec-2004 | Jun-2005 | Dec-2005 | Jun-2006 | Dec-2006 | Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
179
N/A
|
179
N/A
|
187
+4%
|
199
+6%
|
210
+6%
|
222
+6%
|
233
+5%
|
242
+4%
|
254
+5%
|
269
+6%
|
304
+13%
|
337
+11%
|
350
+4%
|
362
+3%
|
369
+2%
|
377
+2%
|
389
+3%
|
407
+4%
|
124
-69%
|
7
-95%
|
189
+2 682%
|
193
+2%
|
194
+0%
|
199
+3%
|
203
+2%
|
213
+5%
|
248
+16%
|
309
+25%
|
359
+16%
|
381
+6%
|
407
+7%
|
444
+9%
|
482
+8%
|
499
+4%
|
515
+3%
|
566
+10%
|
608
+7%
|
641
+5%
|
682
+6%
|
727
+7%
|
762
+5%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(156)
|
(155)
|
(161)
|
(171)
|
(181)
|
(191)
|
(199)
|
(208)
|
(217)
|
(229)
|
(251)
|
(268)
|
(276)
|
(284)
|
(289)
|
(293)
|
(301)
|
(314)
|
(53)
|
66
|
(89)
|
(86)
|
(86)
|
(88)
|
(87)
|
(91)
|
(109)
|
(148)
|
(163)
|
(169)
|
(180)
|
(191)
|
(204)
|
(211)
|
(224)
|
(248)
|
(262)
|
(276)
|
(297)
|
(311)
|
(332)
|
|
Gross Profit |
23
N/A
|
24
+5%
|
25
+5%
|
27
+7%
|
30
+9%
|
32
+6%
|
33
+5%
|
35
+5%
|
37
+6%
|
40
+8%
|
54
+35%
|
69
+28%
|
74
+7%
|
77
+5%
|
81
+4%
|
83
+3%
|
88
+6%
|
93
+5%
|
71
-23%
|
73
+2%
|
101
+39%
|
107
+6%
|
108
+1%
|
110
+3%
|
116
+5%
|
123
+6%
|
139
+13%
|
161
+16%
|
196
+22%
|
212
+8%
|
228
+7%
|
254
+11%
|
278
+10%
|
288
+3%
|
292
+1%
|
318
+9%
|
346
+9%
|
364
+5%
|
385
+6%
|
415
+8%
|
430
+3%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(16)
|
(16)
|
(17)
|
(18)
|
(19)
|
(20)
|
(21)
|
(22)
|
(23)
|
(24)
|
(37)
|
(51)
|
(56)
|
(60)
|
(60)
|
(61)
|
(67)
|
(70)
|
(56)
|
(59)
|
(82)
|
(84)
|
(82)
|
(85)
|
(90)
|
(93)
|
(106)
|
(125)
|
(155)
|
(131)
|
(182)
|
(183)
|
(228)
|
(233)
|
(233)
|
(244)
|
(259)
|
(261)
|
(284)
|
(321)
|
(405)
|
|
Selling, General & Administrative |
0
|
0
|
0
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(0)
|
(32)
|
(67)
|
(70)
|
(40)
|
(39)
|
(74)
|
(76)
|
(57)
|
(77)
|
(63)
|
(75)
|
(75)
|
(106)
|
(100)
|
(105)
|
(110)
|
(119)
|
(126)
|
(134)
|
(135)
|
(141)
|
(151)
|
(158)
|
(179)
|
(199)
|
(207)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(10)
|
(13)
|
(15)
|
(22)
|
(18)
|
(22)
|
(25)
|
(27)
|
(28)
|
(30)
|
(32)
|
(31)
|
(32)
|
(45)
|
(58)
|
|
Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(3)
|
(6)
|
(7)
|
(7)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(17)
|
0
|
(18)
|
(9)
|
(20)
|
(6)
|
(40)
|
(4)
|
(54)
|
(42)
|
(77)
|
(73)
|
(70)
|
(73)
|
(75)
|
(72)
|
(73)
|
(76)
|
(140)
|
|
Other Operating Expenses |
(15)
|
(15)
|
(16)
|
(17)
|
(19)
|
(20)
|
0
|
(22)
|
(23)
|
(24)
|
(34)
|
(45)
|
(49)
|
(52)
|
(53)
|
(29)
|
0
|
0
|
(17)
|
(17)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
8
N/A
|
8
+7%
|
9
+6%
|
10
+15%
|
11
+13%
|
12
+3%
|
12
+7%
|
13
+6%
|
14
+6%
|
15
+11%
|
16
+5%
|
18
+9%
|
18
+1%
|
17
-3%
|
21
+23%
|
22
+6%
|
22
-2%
|
23
+5%
|
15
-36%
|
13
-12%
|
18
+41%
|
23
+25%
|
26
+12%
|
25
-3%
|
26
+6%
|
30
+11%
|
33
+11%
|
36
+10%
|
41
+13%
|
81
+97%
|
45
-44%
|
71
+57%
|
51
-28%
|
55
+8%
|
59
+8%
|
75
+27%
|
87
+17%
|
103
+18%
|
102
-1%
|
95
-7%
|
25
-74%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(2)
|
2
|
(2)
|
(4)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(5)
|
(2)
|
(1)
|
1
|
0
|
(3)
|
(3)
|
(4)
|
(6)
|
(6)
|
(9)
|
(10)
|
(9)
|
(9)
|
(10)
|
(13)
|
(10)
|
(4)
|
(9)
|
(21)
|
|
Non-Reccuring Items |
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
(1)
|
(2)
|
(1)
|
(1)
|
(5)
|
(5)
|
(0)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(15)
|
(20)
|
(8)
|
(39)
|
(11)
|
(43)
|
(13)
|
(8)
|
(9)
|
(8)
|
(0)
|
(1)
|
(20)
|
(32)
|
(40)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
6
N/A
|
7
+16%
|
7
+11%
|
9
+18%
|
10
+13%
|
10
+4%
|
11
+10%
|
12
+6%
|
13
+7%
|
14
+12%
|
12
-17%
|
12
-1%
|
16
+40%
|
19
+15%
|
18
-5%
|
17
-4%
|
19
+9%
|
18
-1%
|
6
-67%
|
3
-51%
|
12
+313%
|
17
+36%
|
21
+27%
|
24
+11%
|
26
+9%
|
27
+6%
|
15
-47%
|
13
-10%
|
29
+118%
|
35
+22%
|
29
-17%
|
19
-35%
|
28
+47%
|
38
+38%
|
41
+7%
|
57
+39%
|
74
+30%
|
92
+24%
|
78
-16%
|
54
-31%
|
(36)
N/A
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(6)
|
(7)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
7
|
(7)
|
(10)
|
(7)
|
(13)
|
(19)
|
(19)
|
(19)
|
(14)
|
8
|
|
Income from Continuing Operations |
4
|
5
|
5
|
6
|
7
|
7
|
8
|
8
|
9
|
10
|
8
|
8
|
11
|
13
|
13
|
13
|
14
|
14
|
4
|
2
|
11
|
14
|
19
|
22
|
19
|
20
|
13
|
11
|
26
|
32
|
26
|
26
|
21
|
29
|
34
|
44
|
56
|
73
|
58
|
40
|
(28)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
4
N/A
|
5
+18%
|
5
+13%
|
6
+18%
|
7
+17%
|
7
+4%
|
8
+4%
|
8
+7%
|
9
+9%
|
10
+13%
|
8
-16%
|
8
N/A
|
11
+36%
|
13
+17%
|
13
-1%
|
13
-3%
|
14
+12%
|
14
N/A
|
12
-18%
|
14
+16%
|
18
+32%
|
57
+216%
|
59
+4%
|
22
-63%
|
19
-12%
|
20
+5%
|
13
-38%
|
11
-11%
|
26
+131%
|
43
+65%
|
36
-16%
|
25
-32%
|
31
+25%
|
29
-7%
|
34
+19%
|
44
+30%
|
56
+26%
|
73
+31%
|
58
-20%
|
40
-31%
|
(28)
N/A
|
|
EPS (Diluted) |
0.07
N/A
|
0.08
+14%
|
0.09
+13%
|
0.11
+22%
|
0.12
+9%
|
0.12
N/A
|
0.13
+8%
|
0.14
+8%
|
0.15
+7%
|
0.17
+13%
|
0.13
-24%
|
0.11
-15%
|
0.15
+36%
|
0.18
+20%
|
0.18
N/A
|
0.17
-6%
|
0.19
+12%
|
0.19
N/A
|
0.15
-21%
|
0.15
N/A
|
0.2
+33%
|
0.64
+220%
|
0.67
+5%
|
0.25
-63%
|
0.22
-12%
|
0.23
+5%
|
0.14
-39%
|
0.12
-14%
|
0.28
+133%
|
0.45
+61%
|
0.37
-18%
|
0.25
-32%
|
0.3
+20%
|
0.28
-7%
|
0.33
+18%
|
0.41
+24%
|
0.51
+24%
|
0.67
+31%
|
0.53
-21%
|
0.36
-32%
|
-0.25
N/A
|